Engineered NKG2C+ CD8+ TKLR cells exhibit effective antitumor control in mice while mitigating cytokine release syndrome. (jci.org)

Authors: Lupo KB … Hsu KC Journal: Journal of Clinical Investigation Published: 2026-10-20 DOI: https://doi.org/10.1172/JCI193053